A once-weekly injectable glucose-dependent insulinotropic polypeptide/GLP-1 dual agonist conferred up to 14.7% weight loss at 13 weeks for adults with overweight or obesity, according to findings from ...

Scientists led by Dr. Timo Müller from Helmholtz Munich and the German Center for Diabetes Research (DZD) have now discovered that glucose-dependent insulinotropic polypeptide (GIP) decreases body ...

BAAR, CH / / January 19, 2026 / PolyPeptide Group AG (SIX:PPGN), a specialized global CDMO for peptide-based active pharmaceutical ingredients, today announced the successful closing of its ...

MINNEAPOLIS & TORRANCE, Calif.--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide manufacturer of innovative filtration and separation products and solutions, and PolyPeptide ...

This collaboration aims to enhance supply chain resilience, improve operational efficiency and accelerate readiness for the rapidly expanding global peptides market. This partnership strengthens LMS ...

There is new research into a new battery technology platform that is completely metal-free. This new battery technology platform utilizes a polypeptide organic radical construction. Almost all Li-ion ...

ZURICH/FRANKFURT, Nov 11 (Reuters) - Family-owned contract manufacturer PolyPeptide is advancing preparations for a 2021 Zurich stock market listing or potential sale, two people close to the matter ...

Investing.com -- PolyPeptide Group AG on Monday reported revenue of €389 million for the financial year 2025, representing a growth rate of 15.6% compared to the previous year.

Significant control over PolyPeptide Group by private companies implies that the general public has more power to influence management and governance-related decisions 56% of the company is held by a ...